Literature DB >> 10147003

Regulation of the pharmaceutical industry and now pharmacoeconomic research?

N E Wells1.   

Abstract

Mesh:

Year:  1992        PMID: 10147003     DOI: 10.2165/00019053-199202060-00002

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  7 in total

1.  Discounting and health benefits.

Authors:  M Parsonage; H Neuburger
Journal:  Health Econ       Date:  1992-04       Impact factor: 3.046

2.  Cost-effectiveness guidelines for reimbursement of pharmaceuticals: is economic evaluation ready for its enhanced status?

Authors:  M Drummond
Journal:  Health Econ       Date:  1992-07       Impact factor: 3.046

3.  Discounting and health benefits: another perspective.

Authors:  J Cairns
Journal:  Health Econ       Date:  1992-04       Impact factor: 3.046

4.  Economic analysis as an aid to subsidisation decisions: the development of Australian guidelines for pharmaceuticals.

Authors:  D Henry
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

5.  Discounting of health benefits in the pharmacoeconomic analysis of drug therapies: an issue for debate?

Authors:  D Coyle; K Tolley
Journal:  Pharmacoeconomics       Date:  1992-08       Impact factor: 4.981

Review 6.  Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?

Authors:  S Birch; A Gafni
Journal:  J Health Econ       Date:  1992-10       Impact factor: 3.883

7.  Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.

Authors:  A L Hillman; J M Eisenberg; M V Pauly; B S Bloom; H Glick; B Kinosian; J S Schwartz
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

  7 in total
  2 in total

1.  Is there a need for an independent centre for pharmacoeconomics in the UK?

Authors:  T Walley; R T Edwards
Journal:  Pharmacoeconomics       Date:  1994-02       Impact factor: 4.981

2.  Issues in the conduct of economic evaluations of pharmaceutical products.

Authors:  M F Drummond
Journal:  Pharmacoeconomics       Date:  1994-11       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.